Literature DB >> 1845867

Endothelin action in rat liver. Receptors, free Ca2+ oscillations, and activation of glycogenolysis.

C Serradeil-Le Gal1, C Jouneaux, A Sanchez-Bueno, D Raufaste, B Roche, A M Préaux, J P Maffrand, P H Cobbold, J Hanoune, S Lotersztajn.   

Abstract

High affinity binding sites for endothelin (ET) were identified on rat liver plasma membranes. Binding of 125I-ET-1 with its site was specific, saturable, and time dependent (kobs = 0.019 +/- 0.001 min-1), but dissociation of receptor-bound ligand was minimal. A single class of high affinity binding sites for 125I-ET-1 was identified with an apparent Kd of 32.4 +/- 9.8 pM and a Bmax of 1084 +/- 118 fmol/mg protein. ET-3 and big-ET-1 (1-38) (human) inhibited 125I-ET-1 binding with IC50 values of 1.85 +/- 1.03 nM and 43 +/- 6 nM, respectively. Aequorin measurements of cytosolic free Ca2+ in single, isolated rat hepatocytes showed that ET-1 at subnanomolar concentrations induced a series of repetitive, sustained Ca2+ transients. ET-1 had no effect on cAMP production. Finally, ET-1 caused a rapid and sustained stimulation of glycogenolysis in rat hepatocytes. A 1.8-fold maximal increase in glycogen phosphorylase alpha was observed at 1 pM ET-1, with an EC50 of 0.03 pM. Stimulation of the enzyme was specific for ET-1 since the order of potency of related peptides was similar to that in binding experiments (ET-1 greater than ET-3 greater than big ET-1). These data constitute the first demonstration of the presence of ET-1 binding sites in liver which is associated with a rise in cytosolic free Ca2+ and a potent glycogenolytic effect. We conclude that ET-1 behaves as a typical Ca2+ mobilizing hormone in liver.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845867      PMCID: PMC295008          DOI: 10.1172/JCI114962

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts.

Authors:  N Takuwa; Y Takuwa; M Yanagisawa; K Yamashita; T Masaki
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

2.  Endothelin binding to cultured calf adrenal zona glomerulosa cells and stimulation of aldosterone secretion.

Authors:  E N Cozza; C E Gomez-Sanchez; M F Foecking; S Chiou
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

3.  Functional endothelin/sarafotoxin receptors in the rat uterus.

Authors:  D Bousso-Mittler; Y Kloog; Z Wollberg; A Bdolah; E Kochva; M Sokolovsky
Journal:  Biochem Biophys Res Commun       Date:  1989-08-15       Impact factor: 3.575

4.  Endothelin-induced increases in vascular smooth muscle Ca2+ do not depend on dihydropyridine-sensitive Ca2+ channels.

Authors:  T Mitsuhashi; R C Morris; H E Ives
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

5.  Two distinct types of endothelin receptors are present on chick cardiac membranes.

Authors:  H Watanabe; H Miyazaki; M Kondoh; Y Masuda; S Kimura; M Yanagisawa; T Masaki; K Murakami
Journal:  Biochem Biophys Res Commun       Date:  1989-06-30       Impact factor: 3.575

6.  Specific receptor for endothelin in cultured rat cardiocytes.

Authors:  Y Hirata; Y Fukuda; H Yoshimi; T Emori; M Shichiri; F Marumo
Journal:  Biochem Biophys Res Commun       Date:  1989-05-15       Impact factor: 3.575

7.  Identification and characterization of endothelin binding sites in rat renal papillary and glomerular membranes.

Authors:  E R Martin; P A Marsden; B M Brenner; B J Ballermann
Journal:  Biochem Biophys Res Commun       Date:  1989-07-14       Impact factor: 3.575

8.  Characterization of renal glomerular endothelin receptors in the rat.

Authors:  G Gauquelin; G Thibault; R Garcia
Journal:  Biochem Biophys Res Commun       Date:  1989-10-16       Impact factor: 3.575

9.  Angiotensin II and phorbol-esters potently down-regulate endothelin (ET-1) binding sites in vascular smooth muscle cells.

Authors:  P Roubert; V Gillard; P Plas; J M Guillon; P E Chabrier; P Braquet
Journal:  Biochem Biophys Res Commun       Date:  1989-10-31       Impact factor: 3.575

10.  A novel peptide, vasoactive intestinal contractor, of a new (endothelin) peptide family. Molecular cloning, expression, and biological activity.

Authors:  K Saida; Y Mitsui; N Ishida
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

View more
  17 in total

Review 1.  Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.

Authors:  H Reynaert; M G Thompson; T Thomas; A Geerts
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

2.  Attenuation of ischemic liver injury by monoclonal anti-endothelin antibody, AwETN40.

Authors:  A Urakami; S Todo; Y Zhu; S Zhang; M B Jin; N Ishizaki; T Shimamura; E Totsuka; V Subbotin; R Lee; T E Starzl
Journal:  J Am Coll Surg       Date:  1997-10       Impact factor: 6.113

3.  Sinusoidal endothelial liver cells in vitro release endothelin--augmentation by transforming growth factor beta and Kupffer cell-conditioned media.

Authors:  H Rieder; G Ramadori; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1991-06-18

4.  Action of endothelins on hepatic stellate cells.

Authors:  N Kawada; T Kuroki; K Kobayashi; M Inoue; K Kaneda; K Decker
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

5.  Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors.

Authors:  A Mallat; A M Préaux; C Serradeil-Le Gal; D Raufaste; C Gallois; D A Brenner; C Bradham; J Maclouf; V Iourgenko; L Fouassier; D Dhumeaux; P Mavier; S Lotersztajn
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

6.  Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway.

Authors:  A Mallat; L Fouassier; A M Préaux; C S Gal; D Raufaste; J Rosenbaum; D Dhumeaux; C Jouneaux; P Mavier; S Lotersztajn
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Hepatic effects of endothelin. Receptor characterization and endothelin-induced signal transduction in hepatocytes.

Authors:  C R Gandhi; R H Behal; S A Harvey; T A Nouchi; M S Olson
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

8.  Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats.

Authors:  C Thirunavukkarasu; Y Yang; V M Subbotin; S A K Harvey; J Fung; C R Gandhi
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

9.  Endothelin and vascular function in liver disease.

Authors:  K Moore
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

10.  Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1.

Authors:  C Housset; D C Rockey; D M Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.